Detalhe da pesquisa
1.
Dupilumab provides sustained effectiveness on patient-reported outcomes and favorable safety in patients with moderate-to-severe atopic dermatitis: Up to 5-year results from the daily practice BioDay registry.
J Am Acad Dermatol
; 2024 Apr 21.
Artigo
Inglês
| MEDLINE | ID: mdl-38653344
2.
Real-world Experience of Abrocitinib Treatment in Patients with Atopic Dermatitis and Hand Eczema: Up to 28-week Results from the BioDay Registry.
Acta Derm Venereol
; 104: adv19454, 2024 02 07.
Artigo
Inglês
| MEDLINE | ID: mdl-38323500
3.
Successful tapering of dupilumab in patients with atopic dermatitis with low disease activity: a large pragmatic daily practice study from the BioDay registry.
Br J Dermatol
; 189(3): 327-335, 2023 08 24.
Artigo
Inglês
| MEDLINE | ID: mdl-37177895
4.
Effectiveness of Upadacitinib in Patients with Atopic Dermatitis including those with Inadequate Response to Dupilumab and/or Baricitinib: Results from the BioDay Registry.
Acta Derm Venereol
; 103: adv00872, 2023 Feb 16.
Artigo
Inglês
| MEDLINE | ID: mdl-36794894
5.
Identification of Risk Factors for Dupilumab-associated Ocular Surface Disease in Patients with Atopic Dermatitis.
Acta Derm Venereol
; 102: adv00666, 2022 Mar 11.
Artigo
Inglês
| MEDLINE | ID: mdl-35098318
6.
Daily Practice Experience of Baricitinib Treatment for Patients with Difficult-to-Treat Atopic Dermatitis: Results from the BioDay Registry.
Acta Derm Venereol
; 102: adv00820, 2022 Nov 24.
Artigo
Inglês
| MEDLINE | ID: mdl-36420885
7.
Dupilumab shows long-term effectiveness in a large cohort of treatment-refractory atopic dermatitis patients in daily practice: 52-Week results from the Dutch BioDay registry.
J Am Acad Dermatol
; 84(4): 1000-1009, 2021 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-32946967
8.
Rapid and Sustained Effect of Dupilumab on Work Productivity in Patients with Difficult-to-treat Atopic Dermatitis: Results from the Dutch BioDay Registry.
Acta Derm Venereol
; 101(10): adv00573, 2021 Oct 19.
Artigo
Inglês
| MEDLINE | ID: mdl-34396421
9.
Two-year drug survival of dupilumab in a large cohort of difficult-to-treat adult atopic dermatitis patients compared to cyclosporine A and methotrexate: Results from the BioDay registry.
Allergy
; 75(9): 2376-2379, 2020 09.
Artigo
Inglês
| MEDLINE | ID: mdl-32302412
10.
Dupilumab Drug Survival and Associated Predictors in Patients With Moderate to Severe Atopic Dermatitis: Long-term Results From the Daily Practice BioDay Registry.
JAMA Dermatol
; 158(9): 1048-1056, 2022 09 01.
Artigo
Inglês
| MEDLINE | ID: mdl-35947364
11.
Topical corticosteroids in atopic dermatitis and the risk of glaucoma and cataracts.
J Am Acad Dermatol
; 64(2): 275-81, 2011 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-21122943
12.
Enteric-coated mycophenolate sodium versus cyclosporin A as long-term treatment in adult patients with severe atopic dermatitis: a randomized controlled trial.
J Am Acad Dermatol
; 64(6): 1074-84, 2011 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-21458107
13.
Bone mineral density in children with moderate to severe atopic dermatitis.
J Am Acad Dermatol
; 63(5): 824-31, 2010 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-20850893
14.
The Self-administered Eczema Area and Severity Index in children with moderate to severe atopic dermatitis: better estimation of AD body surface area than severity.
Pediatr Dermatol
; 27(5): 470-5, 2010.
Artigo
Inglês
| MEDLINE | ID: mdl-20796235
15.
Switching to Interleukin-23 Inhibitors After Ineffectiveness of Ustekinumab: Evaluating Real-World Outcomes in Psoriasis Treatment.
Am J Clin Dermatol
; 2024 May 27.
Artigo
Inglês
| MEDLINE | ID: mdl-38802618
16.
Reply: To PMID 22421118.
J Am Acad Dermatol
; 68(1): 182-3, 2013 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-23244379
17.
The positive effect of dupilumab on comorbid asthma in patients with atopic dermatitis.
Clin Transl Allergy
; 13(1): e12219, 2023 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-36705510
18.
Two-year assessment of effect of topical corticosteroids on bone mineral density in adults with moderate to severe atopic dermatitis.
J Am Acad Dermatol
; 66(4): 691-3, 2012 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-22421118
19.
Percutaneous absorption of potent topical corticosteroids in patients with severe atopic dermatitis.
J Am Acad Dermatol
; 63(5): 911-3, 2010 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-20950744
20.
Differential usefulness of biomarkers thymus and activation-regulated chemokine and soluble CD30 during enteric coated mycophenolate sodium and cyclosporine therapy in atopic dermatitis.
J Am Acad Dermatol
; 63(3): e70-2, 2010 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-20708466